Shukra Pharmaceuticals logo

Shukra Pharmaceuticals

SHUKRAPHAR NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹2,391 Cr
Volatility
High Risk
P/E Ratio
66.59
EBITDA
₹28.73 Cr
Return on Equity
15.24%
Debt to Equity
0.06
Book Value
₹2.27
52W High
₹58.2
52W Low
₹40.06

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

4
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 175% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.2%

Weaknesses

2
  • Stock is trading at 26.3 times its book value
  • Debtor days have increased from 122 to 148 days.

Growth Rate

Revenue Growth
54.1% higher than 3Y
Net Income Growth
107% higher than 3Y
Cash Flow Change
252% higher than 3Y
ROE
-52.61% lower than 3Y
ROCE
-36.69% lower than 3Y
EBITDA Margin (Avg.)
1.85% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
20
25
19
11
3
6
11
13
5
6
39
6
24
Expenses
20
20
9
6
2
5
7
6
4
6
12
6
2
Operating Profit
0
5
10
4
1
1
4
7
1
0
27
1
21
OPM %
1.7%
21%
51%
41%
25%
12%
37%
55%
24%
-7%
69%
11%
90%
Other Income
1
0
1
1
1
1
1
1
1
2
1
1
1
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
1
1
1
1
1
1
1
1
1
1
1
1
PBT
0
5
10
5
1
1
4
8
1
0
27
0
20
Tax %
2%
0%
1%
24%
41%
39%
23%
29%
26%
-1090%
24%
568%
26%
Net Profit
0
5
9
4
0
1
3
5
1
2
20
-2
15
EPS in Rs
0.01
0.11
0.22
0.09
0.01
0.01
0.07
0.12
0.02
0.05
0.46
-0.04
0.34
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
3
5
5
5
6
12
11
20
59
75
33
57
75
Expenses
3
4
4
4
4
10
10
18
53
55
20
28
26
Operating Profit
0
1
1
2
2
2
1
3
5
19
13
29
49
OPM %
-10%
24%
28%
30%
29%
13%
13%
14%
9%
26%
39%
51%
65%
Other Income
1
0
0
0
0
0
0
0
1
3
4
5
4
Interest
0
0
0
0
0
0
0
0
0
0
1
1
1
Depreciation
1
0
0
1
1
1
1
2
2
2
3
3
4
PBT
0
0
1
1
1
0
0
1
4
20
13
29
48
Tax %
52%
66%
52%
45%
37%
82%
-90%
26%
1%
7%
28%
23%
—
Net Profit
0
0
0
1
0
0
0
1
4
19
10
22
36
EPS in Rs
0
0
0.01
0.01
0.01
0
0
0.02
0.1
0.42
0.22
0.5
0.81
Div. Payout %
0%
0%
16%
15%
17%
0%
0%
10%
4%
6%
5%
2%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2
2
2
2
2
2
2
2
4
11
44
44
Reserves
12
13
13
13
14
14
14
15
21
47
19
46
Borrowings
1
0
0
4
6
8
10
3
5
3
4
5
Other Liabilities
3
3
4
6
7
10
10
15
45
17
20
23
Total Liabilities
18
17
19
24
28
34
36
35
75
78
87
117
Fixed Assets
10
10
10
14
16
17
18
18
20
20
19
22
CWIP
2
2
2
2
2
2
2
2
2
2
2
12
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
7
6
7
8
11
14
16
16
53
56
65
84
Total Assets
18
17
19
24
28
34
36
35
75
78
87
117
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-2
3
0
1
0
1
1
8
3
-5
8
3
Investing
1
0
-1
-5
-2
-3
-2
-2
-4
-1
-1
-14
Financing
1
-1
0
3
2
2
2
-7
5
12
-5
5
Net Cash Flow
0
1
-1
0
0
0
0
0
4
6
2
-6
Free Cash Flow
-1
2
-1
-4
-2
-2
-1
6
-1
-7
5
-13
CFO/OP
812
237
7
63
25
81
38
292
64
-24
92
17
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
73
71
175
200
345
245
318
132
187
120
98
148
Inventory Days
554
92
112
53
100
169
221
139
25
19
447
320
Days Payable
291
108
400
734
1,161
786
702
303
271
59
414
232
Cash Conversion Cycle
335
54
-112
-480
-717
-372
-163
-32
-58
80
131
236
Working Capital Days
758
258
344
379
440
226
278
57
41
157
404
352
ROCE %
-1%
6%
7%
6%
4%
0%
1%
6%
19%
44%
22%
37%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Shukra Pharmaceuticals insights

60 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

DIIs0.11%Promot.50.96%Public9.38%Others39.55%As ofJun 2026

Documents

Frequently Asked Questions about Shukra Pharmaceuticals

What does Shukra Pharmaceuticals Ltd do?
Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testing[1]
Where is Shukra Pharmaceuticals Ltd (524632) listed?
Shukra Pharmaceuticals Ltd trades as SHUKRAPHAR on the NSE and under code 524632 on the BSE.
Which sector does Shukra Pharmaceuticals Ltd belong to?
Shukra Pharmaceuticals Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Shukra Pharmaceuticals Ltd?
Shukra Pharmaceuticals Ltd has a market capitalisation of ₹2,391 Cr, which places it in the Small Cap band.
What is the PE ratio of Shukra Pharmaceuticals Ltd?
Shukra Pharmaceuticals Ltd trades at a PE ratio of 66.59, against a book value of ₹2.27 per share.
What is the 52-week high and low of Shukra Pharmaceuticals Ltd?
Over the last 52 weeks Shukra Pharmaceuticals Ltd has traded between ₹40.06 and ₹58.2.
Does Shukra Pharmaceuticals Ltd pay dividends?
Shukra Pharmaceuticals Ltd has a dividend yield of 0.02%.
What is the Return on Equity (ROE) of Shukra Pharmaceuticals Ltd?
Shukra Pharmaceuticals Ltd reported a return on equity of 15.24%. Its debt-to-equity ratio is 0.06.

Company Information

Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testing[1]

Website shukrapharmaceuticals.com
CEO Mr. Dakshesh Rameshchandra Shah
Employees 115
Listed 2026-08-14
Face Value ₹ 1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524632.md for Shukra Pharmaceuticals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List